Global Journal of Medical Research, A: Neurology & Nervous System, Volume 23 Issue 3

64. Rose GM, Diamond DM, Pang K, Dunwiddie TV. Primed burst potentiation: lasting synaptic plasticity invoked by physiologically patterned stimulation. In: Haas HL, Buzsàki G. (eds) Synaptic plasticity in the hippocampus. Springer, Berlin, Heidelberg, 1988. 65. Hargreave E. (2006). The neuroplasticity phenomenon of kindling. http://hargreaves.swong . webfactional.com/kindle.htm. (Accessed 5/19/18). 66. Guha A, Yee CM, Heller W, Miller GA. Alterations in the default mode-salience network circuit provide a potential mechanism supporting negativity bias in depression. Psychophysiology 2012; 58 (12). 67. Binder MR: The neuronal excitability spectrum: A new paradigm in the diagnosis, treatment, and prevention of mental illness and its relation to chronic disease. AJCEM; 2021; 9 (6): 187-203. 68. Henkel AW, Welzel O, Groemer T W, et al. Fluoxetine prevents stimulation-dependent fatigue of synaptic vesicle exocytosis in hippocampal neurons. Journal of Neurochemistry 2010; 114 (3): 697-705. 69. Varvin S. Which patients should avoid psychoanalysis, and which professionals should avoid psychoanalytic training?: A critical evaluation. Scandinavian Psychoanalytic Review 2014; 26 (26): 109-122. 70. Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021; 55 (1): 7-117. 71. Binder MR. A pathophysiolgically-based approach to the treatment and prevention of mental illness and its related disorders. AJCEM 2021; 9 (6): 223-232. 72. Shah B, Elsayed OH, El-Mallakh RS. Bipolar disorder: The foundational role of mood stabilizers. Current Psychiatry 2023; 22 (5): 36-41. 73. Weitz E, Hollon SD, Twisk J, et al.Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data meta- analysis. JAMA Psychiatry 2015; 72:1102–1109. 74. Cuijpers P, De Wit L, Weitz E, et al. The combination of psychotherapy and pharmacotherapy in the treatment of adult depression: a comprehensive meta-analysis. J Evid Based Psychother 2015; 15: 147–168. 75. Khedr EM, Elserogy Y, Fawzy M. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study. Psychiatry Research 2020; 291: 113287. 76. Godlewska BR, Norbury R, Selvaraj S, Cowen PJ, Harmer CJ. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med 2012; 42 (12): 2609-2617. 77. Hett D, Marwaha S. Repetitive transcranial magnetic stimulation in the treatment of bipolar disorder. Ther Adv Psychopharmacol 2020; 18 (10). 78. Marzouk T, Winkelbeiner S, Azizi H, et al. Transcranial magnetic stimulation for positive symptoms in schizophrenia: A systematic review. Neuropsychobiology 2020; 79: 384–396. 79. Binder MR. Neuronal hyperexcitability: The elusive but modifiable instigator of disease. AJCEM 2022; 10 (1): 1-7. 80. Grunze HCR. The effectiveness of anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci. 2008; 10 (1): 77-89. 81. Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011; 477: 171-178. 82. Binder MR. Electrophysiology of seizure disorders may hold key to the pathophysiology of psychiatric disorders. AJCEM 2019; 7 (5): 103-110. 83. Binder MR. Neuronal hyperexcitability: significance, cause, and diversity of clinical expression. AJCEM 2021; 9 (5); 157-167. 84. Binder MR. Suicide: A new hypothesis on the pathogenesis of disease, method of screening, and means of prevention. AJPN 2022; 10 (3): 111-124. 85. Canadian Health Measures Survey: Cycle 2 Data Tables: Table 3 — Average resting heart rate, by age and sex, household population, Canada, 2009 to 2011. 86. Wallis LA, Healy M, Unde MB, Maconochi I. Age related reference ranges for respiration rate and heart rate from 4 to 16 years. Arch Dis Child 2005; 90: 1117-1121. 87. Binder MR. Gabapentin—The popular but controversial anticonvulsant drug may be zeroing in on the pathophysiology of disease. AJCEM 2021; 9 (4): 122-134. 88. Young LT. What is the best treatment for bipolar depression? J Psychiatry Neurosci 2008; 33 (6): 487-488. 89. Lubloy A, Kereszturi JL, Nemeth A, Mihalicza P. Exploring factors of diagnostic delay for patients with bipolar disorder: a population-based cohort study. BMC Psychiatry 2020; 20 (75). 90. Dagani J, Signorini G, Nielssen O, et al. Meta- analysis of the interval between the onset and management of bipolar disorder. The Canadian Journal of Psychiatry 2016; 64 (4). 91. Hirschfeld R, Lewis L, Vornik L. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64 (2): 161-174. 92. Campbell D. People with bipolar disorder may wait 13 years for diagnosis. The Guardian 2012; 14 Year 2023 Global Journal of Medical Research Volume XXIII Issue III Version I ( D ) A © 2023 Global Journals Untangling Psychology from Biology in the Treatment of Psychiatric Disorders